- Report
- August 2025
- 184 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- August 2025
- 192 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- August 2025
- 189 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- August 2025
- 198 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- January 2026
- 182 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- January 2026
- 180 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- April 2025
Global
From €4259EUR$4,900USD£3,706GBP
- Report
- December 2025
- 250 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- September 2025
- 250 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- April 2025
- 175 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- April 2025
- 175 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- February 2026
- 371 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 280 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 379 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- January 2026
- 181 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- August 2025
- 188 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- October 2025
- 250 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- April 2025
- 175 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- April 2025
- 175 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- April 2025
- 175 Pages
Global
From €3902EUR$4,490USD£3,396GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more